FDA review News
Most Popular FDA review Story
Doctor demands halt to FDA review of Lilly's prasugrel
One of the doctors involved in an early clinical study of Eli Lilly's prasugrel, a potential blockbuster and one of the company's biggest new drug prospects, has joined with two consumer advocates at Read more...
Latest Headlines
- April 25, 2011
- September 30, 2009
- September 23, 2009
- September 11, 2009
- September 8, 2009
- August 28, 2009
- August 13, 2009
- August 13, 2009
- July 20, 2009
- July 13, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
